Scott Mendel's most recent trade in Quantum-Si Incorporated - Ordinary Shares - Class A was a trade of 126,095 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 19, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Quantum-Si Incorporated - ... | Scott Mendel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 126,095 | 126,095 | - | - | Stock Option (right to buy) | |
Akoya Biosciences Inc | Scott Mendel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2024 | 44,959 | 44,959 | - | - | Stock Option (right to buy) | |
Akoya Biosciences Inc | Scott Mendel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
Quantum-Si Incorporated - ... | Scott Mendel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 113,281 | 113,281 | - | - | Stock Option (right to buy) | |
Akoya Biosciences Inc | Scott Mendel | Director | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 12 Jun 2023 | 20,000 | 28,500 | - | 5 | 100,000 | Common Stock |
Akoya Biosciences Inc | Scott Mendel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 56,322 | 56,322 | - | - | Stock Option (Right to Buy) | |
Quantum-Si Incorporated - ... | Scott Mendel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 141,843 | 141,843 | - | 0 | Class A Common Stock | |
Akoya Biosciences Inc | Scott Mendel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 30,549 | 30,549 | - | - | Stock Option (Right to Buy | |
Akoya Biosciences Inc | Scott Mendel | Director | Purchase of securities on an exchange or from another person at price $ 13.16 per share. | 19 Nov 2021 | 8,500 | 8,500 | - | 13.2 | 111,860 | Common Stock |
Akoya Biosciences Inc | Scott Mendel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 35,562 | 35,562 | - | - | Stock Option (Right to Buy |